Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS

Analytical and Bioanalytical Chemistry

Volumn 391, Issue 1, 2008, Pages 251-261

  Thevis, Mario ^a   Kohler, Maxie ^a   Thomas, Andreas ^a   Maurer, Joachim ^a   Schlörer, Nils ^b   Kamber, Matthias ^c   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Federal Office of Sports   (Switzerland)

Author keywords

Doping; Fragmentation; Liquid chromatography; Mass spectrometry; Precursor ion scan; SARMs; Sport

Indexed keywords

AGONISTS; FRAGMENTATION; PRECURSOR ION SCAN; SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS);

BIOASSAY; BODY FLUIDS; DOPING (ADDITIVES); ELECTROSPRAY IONIZATION; HORMONES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; TISSUE;

DRUG PRODUCTS;

5,6 DICHLOROBENZIMIDAZOLE; 5,6-DICHLOROBENZIMIDAZOLE; ANDROGEN RECEPTOR; ANTIANDROGEN; BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; BICYCLO COMPOUND; HYDANTOIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG POTENTIATION; HUMAN; LIQUID CHROMATOGRAPHY; MASS SCREENING; METHODOLOGY; SYNTHESIS; TANDEM MASS SPECTROMETRY; URINE; VALIDATION STUDY;

ANDROGEN ANTAGONISTS; BENZIMIDAZOLES; BICYCLO COMPOUNDS; CHROMATOGRAPHY, LIQUID; HUMANS; HYDANTOINS; MASS SCREENING; MOLECULAR STRUCTURE; RECEPTORS, ANDROGEN; TANDEM MASS SPECTROMETRY;

EID: 42449084465     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-008-1882-6     Document Type: Article

References (39)

1. Bhasin S, Calof OM, Storer TW, Lee ML, Mazer NA, Jasuja R, Montori VM, Gao W, Dalton JT (2006) Nat Clin Pract Endocrinol Metab 2:146-159
2. Hengge UR (2003) AIDS Read 13:S15-S21
3. Moretti C, Frajese GV, Guccione L, Wannenes F, De Martino MU, Fabbri A, Frajese G (2005) J Endocrinol Invest 28:56-64
4. Gooren LJ, Bunck MC (2004) Drugs 64:1861-1891
5. Dalton JT, Mukherjee A, Zhu Z, Kirkovsky L, Miller DD (1998) Biochem Biophys Res Commun 244:1-4
6. Mohler ML, Nair VA, Hwang DJ, Rakov IM, Patil R, Miller DD (2005) Exp Opin Ther Patents 15:1565-1585
7. Chen J, Kim J, Dalton JT (2005) Mol Interv 5:173-188
8. Negro-Vilar A (1999) J Clin Endocrinol Metab 84:3459-3462
9. Gao W, Dalton JT (2007) Drug Discov Today 12:241-248
10. Thevis M, Schänzer W (2007) Mini-Rev Med Chem 7:533-539
11. Omwancha J, Brown TR (2006) Curr Opin Investig Drugs 7:873-881
12. World Anti-Doping Agency (2008) The 2008 Prohibited List. http://www.wada-ama.org/rtecontent/document/2008_List_En.pdf. Accessed 28 Nov 2007
13. Thevis M, Kohler M, Maurer J, Schlörer N, Kamber M, Schänzer W (2007) Rapid Commun Mass Spectom 21:3477-3486
14. Thevis M, Kamber M, Schänzer W (2006) Rapid Commun Mass Spectrom 20:870-876
15. Thevis M, Kohler M, Schänzer W (2007) Mass spectrometry of new growth promoting drugs: hydantoin-derived selective androgen receptor modulators and growth hormone secretagogues. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds) Recent advances in doping analysis. Sport und Buch Strauß, Cologne (in press)
16. Ng RA, Guan J, Alford VC, Jr., Lanter JC, Allan GF, Sbriscia T, Lundeen SG, Sui Z (2007) Bioorg Med Chem Lett 17:955-958
17. Ng RA, Guan J, Alford VC Jr, Lanter JC, Allan GF, Sbriscia T, Linton O, Lundeen SG, Sui Z (2007) Bioorg Med Chem Lett 17:784-788
18. Ostrowski J, Kuhns JE, Lupisella JA, Manfredi MC, Beehler BC, Krystek SR, Jr., Bi Y, Sun C, Seethala R, Golla R, Sleph PG, Fura A, An Y, Kish KF, Sack JS, Mookhtiar KA, Grover GJ, Hamann LG (2006) Endocrinology 48:4-12
19. Sun C, Robl JA, Wang TC, Huang Y, Kuhns JE, Lupisella JA, Beehler BC, Golla R, Sleph PG, Seethala R, Fura A, Krystek SR, Jr., An Y, Malley MF, Sack JS, Salvati ME, Grover GJ, Ostrowski J, Hamann LG (2006) J Med Chem 49:7596-7599
20. Ng RA, Lanter JC, Alford VC, Allan GF, Sbriscia T, Lundeen SG, Sui Z (2007) Bioorg Med Chem Lett 17:1784-1787
21. Handelsman DJ (2004) Sci STKE 244:pe41
22. Catlin DH, Ahrens BD, Kucherova Y (2002) Rapid Commun Mass Spectrom 16:1273-1275
23. Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang Y-C, Hatton CK (2004) Rapid Commun Mass Spectrom 18:1245-1249
24. Sekera MH, Ahrens BD, Chang YC, Starcevic B, Georgakopoulos C, Catlin DH (2005) Rapid Commun Mass Spectrom 19:781-784
25. Thevis M, Schänzer W (2005) J Chromatogr Sci 43:22-31
26. ICH (2005) Validation of analytical procedures: text and methodology. http://www.ich.org/LOB/media/MEDIA417.pdf. Accessed 28 Jan 2008
27. Kromidas A (1999) Validierung in der Analytik. Wiley-VCH, Weinheim
28. Dams R, Huestis MA, Lambert WE, Murphy CM (2003) J Am Soc Mass Spectrom 14:1290-1294
29. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Anal Chem 75:3019-3030
30. Thevis M, Geyer H, Mareck U, Schänzer W (2005) J Mass Spectrom 40:955-962
31. Mazzarino M, Botre F (2006) Rapid Comm Mass Spectrom 20:3465-3476
32. Kolmonen M, Leinonen A, Pelander A, Ojanpera I (2007) Anal Chim Acta 585:94-102
33. Georgakopoulos CG, Vonaparti A, Stamou M, Kiousi P, Lyris E, Angelis YS, Tsoupras G, Wuest B, Nielen MW, Panderi I, Koupparis M (2007) Rapid Commun Mass Spectrom 21:2439-2446
34. Nielen MW, Bovee TF, van Engelen MC, Rutgers P, Hamers AR, van Rhijn JH, Hoogenboom LR (2006) Anal Chem 78:424-431
35. Jemal M, Ouyang Z, Zhao W, Zhu M, Wu WW (2003) Rapid Commun Mass Spectrom 17:2732-2740
36. Hakala KS, Kostiainen R, Ketola RA (2006) Rapid Commun Mass Spectrom 20:2081-2090
37. Li AC, Gohdes MA, Shou WZ (2007) Rapid Commun Mass Spectrom 21:1421-1430
38. Xia YQ, Miller JD, Bakhtiar R, Franklin RB, Liu DQ (2003) Rapid Commun Mass Spectrom 17:1137-1145
39. Thevis M, Kohler M, Schlörer N, Kamber M, Kuhn A, Linscheid MW, Schänzer W (2007) J Mass Spectrom. DOI 10.1002/jms.1364